Literature DB >> 9468250

Liver damage in human small intestinal bacterial overgrowth.

S M Riordan1, C J McIver, R Williams.   

Abstract

OBJECTIVE: Some rodent strains with experimental small intestinal bacterial overgrowth (SIBO) unrelated to jejunoileal bypass are susceptible to hepatic damage, possibly because of increased small intestinal permeability to proinflammatory bacterial polymers. However, data on the prevalence of hepatic damage in human subjects with SIBO in this setting are lacking. This study addressed this issue.
METHODS: Seventy adult subjects were investigated for possible SIBO and hepatic damage with bacteriological analysis of small intestinal aspirates and measurement of serum concentrations of alkaline phosphatase, gamma-glutamyl transpeptidase, aspartate aminotransferase, and alanine aminotransferase. Nutritional indices (serum albumin and anthropometry) and the urinary lactulose/mannitol ratio, an index of small intestinal permeability, were measured in all subjects with SIBO and liver damage.
RESULTS: SIBO was present in 40 of 70 subjects (57.1%). Overgrowth flora included salivary-type bacteria alone in 11 subjects and colonic-type bacteria in 29 subjects (facultative anaerobes [Enterobacteriaceae] alone in 21 subjects and both facultative and obligate anaerobes [Enterobacteriaceae and Bacteroides spp] in eight subjects). Biochemical evidence of liver damage was found in zero of 30 subjects without SIBO, zero of 11 subjects with SIBO with salivary-type bacteria alone, zero of 21 subjects with SIBO with facultative but not obligate anaerobic colonic-type bacteria, and in one of eight subjects (12.5%) with SIBO with obligate anaerobic colonic-type bacteria, in whom serum alkaline phosphatase and gamma-glutamyl transpeptidase levels were elevated. Nutritional indices were normal in this patient. Small intestinal permeability was increased and, along with liver enzyme abnormalities, normalized after eradication of SIBO. Small intestinal permeability was also increased in three of six patients (50.0%) with SIBO with obligate anaerobic colonic-type bacteria who had no evidence of liver damage.
CONCLUSIONS: SIBO per se is not a major risk factor for liver damage in humans, even when the overgrowth flora includes obligate anaerobes. Liver damage is not a necessary consequence of increased small intestinal permeability in this setting.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468250     DOI: 10.1111/j.1572-0241.1998.00234.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  Small intestinal bacterial overgrowth, intestinal permeability, and non-alcoholic steatohepatitis.

Authors:  S M Riordan; V M Duncombe; M C Thomas; A Nagree; T D Bolin; C J McIver; R Williams
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

2.  Changes in intestinal permeability after Roux-en-Y gastric bypass.

Authors:  Alexandre Lages Savassi-Rocha; Marco Túlio Costa Diniz; Eduardo Garcia Vilela; Maria de Fátima Haueisen Sander Diniz; Soraya Rodrigues de Almeida Sanches; Aloísio Sales da Cunha; Maria de Lourdes de Abreu Ferrari; Henrique Oswaldo da Gama Torres; Bruno Antonio Maciente; Gabriela Santana Ataliba; Paloma Maciel Araújo; Taciana Bretas Guerra; Inara Kellen Fonseca Balbino
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

3.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

4.  Low-grade small intestinal bacterial overgrowth is common in patients with non-alcoholic steatohepatitis on quantitative jejunal aspirate culture.

Authors:  Uday C Ghoshal; Chalamalasetty Sreenivasa Baba; Ujjala Ghoshal; George Alexander; Asha Misra; Vivek A Saraswat; Gourdas Choudhuri
Journal:  Indian J Gastroenterol       Date:  2017-10-16

5.  Intestinal expressions of eNOSmRNA and iNOSmRNA in rats with acute liver failure.

Authors:  J M Qin; Y D Zhang
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

6.  Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index <35 kg/m2. A cohort study.

Authors:  Munir Alamo; Matías Sepúlveda; José Gellona; Mauricio Herrera; Cristián Astorga; Carlos Manterola
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

Review 7.  Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis.

Authors:  Yaron Ilan
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

8.  Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates.

Authors:  Kylie Kavanagh; Ashley T Wylie; Kelly L Tucker; Timothy J Hamp; Raad Z Gharaibeh; Anthony A Fodor; John M Cullen Cullen
Journal:  Am J Clin Nutr       Date:  2013-08       Impact factor: 7.045

9.  Dysfunction of organic anion transporting polypeptide 1a1 alters intestinal bacteria and bile acid metabolism in mice.

Authors:  Youcai Zhang; Pallavi B Limaye; Lois D Lehman-McKeeman; Curtis D Klaassen
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

10.  Safety and efficacy of a side-to-side duodeno-ileal anastomosis for weight loss and type-2 diabetes: duodenal bipartition, a novel metabolic surgery procedure.

Authors:  Michel Gagner
Journal:  Ann Surg Innov Res       Date:  2015-10-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.